Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (19 quarters reported)
$2.5M in Q1 2019 → $783 now. Hover for any quarter.
As reported for the quarter ended September 30, 2023. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Heron Therapeutics Inc | 100.0% | Unchanged | 760 | $783 |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2023 · filed November 14, 2023
No position changes this quarter.
quarter ended June 30, 2023 · filed August 14, 2023
No position changes this quarter.
quarter ended March 31, 2023 · filed May 15, 2023
No position changes this quarter.
quarter ended December 31, 2022 · filed February 14, 2023
No position changes this quarter.
quarter ended September 30, 2022 · filed November 14, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| LJ La Jolla Pharmaceutical Co | Exited | −240,000 | −$766K | — |
quarter ended June 30, 2022 · filed August 15, 2022
No position changes this quarter.
quarter ended March 31, 2022 · filed May 16, 2022
No position changes this quarter.
quarter ended December 31, 2021 · filed February 14, 2022
No position changes this quarter.
Loading...
